FABRAZYME
FABRAZYME
Approved
DIN Number
02248966
Drug Class
Human
Market Date
Apr 8, 2004
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02248966
AIG Number0149901002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB04 AGALSIDASE BETA
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
AGALSIDASE BETAActive
Strength: 35 MG / VIAL
Monograph: AGALSIDASE BETA